18 May 2017
The Canadian Centre for Ethics in Sport (CCES) announced today that Connor Visagie, a powerlifting athlete, received a four-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on February 19, 2017, revealed the presence of GW501516, Clomiphene, SARM LGD-4033, SARM RAD-140, SARM S-4, and SARM S-22.
In response to the CCES’ notification of the adverse analytical finding, Mr. Visagie admitted the violation in a timely fashion (in accordance with CADP Rule 10.11.2), waived his right to a hearing and accepted a sanction of four years ineligibility from sport, terminating on February 18, 2021. The athlete, who resides in Chilliwack, British Columbia, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates.
In compliance with rule 7.10 of the CADP, a copy of the CCES’ file summary can be found at www.cces.ca/canadian-sport-sanction-registry.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for inpiduals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.